What is Anand Rajpara's NPI number?

Anand Rajpara's National Provider Identifier (NPI) is 1639494198, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Anand Rajpara's specialty?

Anand Rajpara is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Anand Rajpara located?

Anand Rajpara's practice location on file with NPPES is 19000 E. Eastland Court, Independence, MO 64055.

What is Anand Rajpara's phone number?

The practice phone number listed in the NPPES registry for Anand Rajpara is (816) 404-2900.

Does Anand Rajpara accept Medicare?

Anand Rajpara is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Anand Rajpara's NPI active?

Yes — Anand Rajpara's NPI (1639494198) is active in the NPPES registry as of the last update on 2022-08-18.

IndividualActiveAccepts Medicare

Anand Rajpara, M.D.

NPI 1639494198 · Dermatology Physician · Independence, MO

Anand Rajpara, M.D. is a Dermatology Physician provider in Independence, MO (NPI 1639494198).

Provider details

NPI number: 1639494198
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Male
Sole proprietor: Yes
License: 2017030249 (MO)

Practice location

19000 E. Eastland Court

Independence, MO 64055

Phone: (816) 404-2900

Street-level locationGet directions

More MO providers

Mailing address

2301 Holmes St

Kansas City, MO 64108-2640

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 2017030249 (MO)
Allopathic & Osteopathic Physicians
Dermatology Physician207N00000XLicense 04-37279 (KS)
Allopathic & Osteopathic Physicians

Additional practice locations (2)

3901 Rainbow Blvd # Ms 2025
Kansas City, KS 66160
Phone: (913) 588-3840
2301 Holmes St
Kansas City, MO 64108-2640
Phone: (816) 404-1000

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(73/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
16 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
3 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
652 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	255	$2
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	104	$92
Destruction of Precancer Skin Growth, 1 Growth17000	80	$45
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	66	$62
Biopsy of Related Skin Growth, First Growth11102	45	$25
Destruction of Skin Growth, 1-14 Growths

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 20 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Clobetasol Propionate	152	64
Triamcinolone Acetonide	145	77
Dupilumabbrand: Dupixent Pen	133	18
Ketoconazole	127	55
Hydrocortisone	108	43
Apremilastbrand: Otezla	51	11
Minoxidil	35	—
Tacrolimus

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$46 across 2 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2010-03-28
Last updated: 2022-08-18
Certified: 2022-08-15

Frequently asked questions

What is Anand Rajpara's NPI number?: Anand Rajpara's National Provider Identifier (NPI) is 1639494198, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Anand Rajpara's specialty?: Anand Rajpara is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Anand Rajpara located?: Anand Rajpara's practice location on file with NPPES is 19000 E. Eastland Court, Independence, MO 64055.
What is Anand Rajpara's phone number?: The practice phone number listed in the NPPES registry for Anand Rajpara is (816) 404-2900.
Does Anand Rajpara accept Medicare?: Anand Rajpara is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Anand Rajpara's NPI active?: Yes — Anand Rajpara's NPI (1639494198) is active in the NPPES registry as of the last update on 2022-08-18.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	255	$2
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	104	$92
Destruction of Precancer Skin Growth, 1 Growth17000	80	$45
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	66	$62
Biopsy of Related Skin Growth, First Growth11102	45	$25
Destruction of Skin Growth, 1-14 Growths

Drug

Part D claims (2024)

Beneficiaries

Clobetasol Propionate

152

Triamcinolone Acetonide

145

Dupilumabbrand: Dupixent Pen

133

Ketoconazole

127

Hydrocortisone

108

Apremilastbrand: Otezla

Minoxidil

—

Tacrolimus

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$46 across 2 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (2)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (2)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments